Free Trial

LifeVantage (LFVN) Short Interest Ratio & Short Volume

$7.18
+0.40 (+5.90%)
(As of 05/20/2024 ET)

LifeVantage Short Interest Data

Current Short Interest
78,800 shares
Previous Short Interest
67,600 shares
Change Vs. Previous Month
+16.57%
Dollar Volume Sold Short
$480,680.00
Short Interest Ratio
2.2 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
12,700,000 shares
Float Size
10,080,000 shares
Short Percent of Float
0.78%
Today's Trading Volume
126,369 shares
Average Trading Volume
41,167 shares
Today's Volume Vs. Average
307%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling LifeVantage ?

Sign up to receive the latest short interest report for LifeVantage and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LFVN Short Interest Over Time

LFVN Days to Cover Over Time

LFVN Percentage of Float Shorted Over Time

LifeVantage Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202478,800 shares $480,680.00 +16.6%0.8%2.2 $6.10
4/15/202467,600 shares $388,700.00 +6.1%0.7%1.9 $5.75
3/31/202463,700 shares $385,385.00 -21.7%0.6%1.8 $6.05
3/15/202481,400 shares $569,800.00 -16.5%0.8%2.3 $7.00
2/29/202497,500 shares $664,950.00 +12.6%1.0%2.7 $6.82
2/15/202486,600 shares $562,034.00 +4.7%0.9%2.4 $6.49
1/31/202482,700 shares $439,137.00 -18.8%0.8%1.8 $5.31
1/15/2024101,900 shares $588,982.00 -5.1%1.0%1.8 $5.78
12/31/2023107,400 shares $644,400.00 -15.2%1.1%1.8 $6.00
12/15/2023126,600 shares $792,516.00 -6.0%1.3%2.2 $6.26
11/30/2023134,700 shares $849,957.00 +40.9%1.3%2.1 $6.31
11/15/202395,600 shares $448,364.00 -40.3%1.0%0.9 $4.69
10/31/2023160,000 shares $1.20 million +46.4%1.6%1.7 $7.51
10/15/2023109,300 shares $765,100.00 +3.8%1.1%1.4 $7.00
9/30/2023105,300 shares $679,185.00 -4.8%1.0%1.4 $6.45
9/15/2023110,600 shares $721,112.00 -23.1%1.1%1.5 $6.52
8/31/2023143,800 shares $1.06 million +226.8%1.4%2 $7.40
8/15/202344,000 shares $227,920.00 -9.8%0.4%1.3 $5.18
7/31/202348,800 shares $246,928.00 +1.2%0.5%1.5 $5.06
7/15/202348,200 shares $215,454.00 +6.6%0.4%1.5 $4.47
6/30/202345,200 shares $196,620.00 -17.7%0.4%1.5 $4.35
6/15/202354,900 shares $288,774.00 +24.8%0.5%1.9 $5.26
5/31/202344,000 shares $205,040.00 +10.3%0.4%1.8 $4.66
5/15/202339,900 shares $174,363.00 +19.1%0.4%2.3 $4.37
4/30/202333,500 shares $110,550.00 +3.4%0.3%2.4 $3.30
4/15/202332,400 shares $108,864.00 +0.3%0.3%2.4 $3.36
3/31/202332,300 shares $115,957.00 -12.7%0.3%2.2 $3.59
3/15/202337,000 shares $120,620.00 +2.5%0.3%2.1 $3.26
2/28/202336,100 shares $140,068.00 +0.3%0.3%1.8 $3.88
2/15/202336,000 shares $143,280.00 -0.8%0.3%1.6 $3.98
1/31/202336,300 shares $145,200.00 -0.6%0.3%1.4 $4.00
1/15/202336,500 shares $141,985.00 -17.2%0.3%1.3 $3.89
12/30/202244,100 shares $164,052.00 +8.9%0.4%1.4 $3.72
12/15/202240,500 shares $155,925.00 +6.9%0.4%1.4 $3.85
11/30/202237,900 shares $141,746.00 -7.6%0.3%1.2 $3.74
11/15/202241,000 shares $159,900.00 +2.0%0.4%1.2 $3.90
10/31/202240,200 shares $162,006.00 -35.6%0.4%1.2 $4.03
10/15/202262,400 shares $237,120.00 +28.4%0.6%1.6 $3.80
9/30/202248,600 shares $182,250.00 +9.7%0.4%1.3 $3.75
9/15/202244,300 shares $173,213.00 -6.9%0.4%1.2 $3.91
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report
8/31/202247,600 shares $189,448.00 +4.2%0.4%1.3 $3.98
8/15/202245,700 shares $192,854.00 +18.4%0.4%1.4 $4.22
7/31/202238,600 shares $164,050.00 +1.9%0.3%1.1 $4.25
7/15/202237,900 shares $158,422.00 -24.7%0.3%1.1 $4.18
6/30/202250,300 shares $218,805.00 +25.8%0.4%1.5 $4.35
6/15/202240,000 shares $173,600.00 -13.4%0.3%1.2 $4.34
5/31/202246,200 shares $189,882.00 +6.7%0.4%1.4 $4.11
5/15/202243,300 shares $175,365.00 +2.4%0.4%1.2 $4.05
4/30/202242,300 shares $164,970.00 +4.4%0.4%1 $3.90
4/15/202240,500 shares $187,110.00 -16.2%0.3%0.8 $4.62
3/31/202248,300 shares $229,908.00 -8.5%0.4%1 $4.76
3/15/202252,800 shares $254,496.00 -6.1%0.5%1 $4.82
2/28/202256,200 shares $313,596.00 +19.3%0.5%1 $5.58
2/15/202247,100 shares $251,043.00 -23.4%0.4%0.8 $5.33
1/31/202261,500 shares $395,445.00 -36.7%0.6%1.1 $6.43
1/15/202297,200 shares $635,688.00 +29.4%0.8%2 $6.54
12/31/202175,100 shares $474,632.00 -0.8%0.7%1.6 $6.32
12/15/202175,700 shares $507,190.00 -0.8%0.7%1.6 $6.70
11/30/202176,300 shares $490,609.00 -4.5%0.7%1.6 $6.43
11/15/202179,900 shares $572,084.00 -72.8%0.7%1.6 $7.16
10/29/2021293,300 shares $2.01 million -4.0%2.5%5.1 $6.85
10/15/2021305,400 shares $2.08 million +4.0%2.6%4.8 $6.82
9/30/2021293,800 shares $1.99 million -10.3%2.5%3.4 $6.77
9/15/2021327,700 shares $2.34 million +1.1%2.7%2.4 $7.15
8/31/2021324,300 shares $2.52 million +2.5%2.7%2.3 $7.77
8/13/2021316,500 shares $2.26 million -7.0%2.6%2.2 $7.14
7/30/2021340,300 shares $2.76 million +13.4%2.7%2.4 $8.12
7/15/2021300,200 shares $2.05 million +2.4%2.4%2 $6.84
6/30/2021293,200 shares $2.16 million -50.3%2.3%2.3 $7.35
6/15/2021590,200 shares $4.82 million -7.4%4.7%6.2 $8.16
5/28/2021637,200 shares $5.08 million -3.0%5.1%7.1 $7.97
5/14/2021656,900 shares $5.19 million +9.8%5.2%7 $7.90
4/30/2021598,400 shares $5.22 million +26.8%4.8%5.9 $8.72
4/15/2021472,000 shares $4.15 million -19.7%3.7%4.9 $8.79
3/31/2021587,800 shares $5.54 million -19.1%4.6%6.1 $9.43
3/15/2021726,500 shares $6.80 million -10.2%5.7%7.9 $9.36
2/26/2021809,400 shares $7.18 million +18.9%6.4%9.1 $8.87
2/12/2021680,600 shares $6.21 million +0.7%5.3%7.6 $9.13
1/29/2021675,600 shares $6.06 million -7.0%5.3%7.9 $8.97
1/15/2021726,700 shares $6.85 million +0.9%5.7%9.6 $9.43
12/31/2020720,500 shares $6.74 million -8.3%5.6%9.6 $9.36
12/15/2020786,000 shares $8.71 million -0.8%6.1%11.1 $11.08
11/30/2020792,200 shares $9.00 million +21.0%6.2%11.3 $11.36
11/15/2020654,900 shares $7.30 million -15.2%5.1%8.9 $11.14
10/30/2020771,900 shares $8.82 million +30.9%6.0%11.1 $11.42
10/15/2020589,500 shares $7.79 million +1.8%4.6%9.2 $13.22
9/30/2020578,900 shares $6.99 million +4.5%4.5%9.7 $12.07
9/15/2020553,900 shares $7.57 million -5.5%4.3%8 $13.66
8/31/2020585,800 shares $8.80 million +3.5%4.5%8 $15.02
8/14/2020565,900 shares $7.45 million -2.3%4.3%7.5 $13.16
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! (Ad)

Learn more about why Zack’s has increased its price target on this company to a whopping $23.25!

Click for Zack's full report
7/31/2020579,000 shares $7.43 million -2.0%4.4%7.7 $12.84
7/15/2020590,900 shares $7.91 million -3.3%4.5%6 $13.38
6/30/2020610,900 shares $7.90 million +5.8%4.7%6 $12.93
6/15/2020577,500 shares $8.36 million -6.2%4.4%5.7 $14.48
5/29/2020615,700 shares $9.43 million +1.0%4.7%5.7 $15.31
5/15/2020609,600 shares $8.52 million -5.9%4.7%5.6 $13.98
4/30/2020647,600 shares $10.04 million +0.5%5.0%6 $15.50
4/15/2020644,100 shares $7.68 million -2.8%5.0%6.4 $11.92
3/31/2020662,900 shares $8.66 million -2.9%5.1%6.5 $13.06
3/13/2020682,900 shares $8.09 million +1.9%5.2%7.4 $11.84
2/28/2020670,100 shares $6.62 million +2.4%5.1%7.6 $9.88
2/14/2020654,200 shares $7.81 million +9.2%5.0%7.8 $11.94
1/31/2020599,100 shares $8.26 million -10.2%4.6%7.3 $13.79
1/15/2020667,000 shares $10.56 million -10.9%5.3%8.4 $15.83
12/31/2019748,500 shares $11.41 million -9.1%6.0%8.8 $15.25
8/15/2019634,700 shares $7.43 million -19.3%4.8%5.3 $11.70

LFVN Short Interest - Frequently Asked Questions

What is LifeVantage's current short interest?

Short interest is the volume of LifeVantage shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 78,800 shares of LFVN short. 0.78% of LifeVantage's shares are currently sold short. Learn More on LifeVantage's current short interest.

What is a good short interest ratio for LifeVantage?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LFVN shares currently have a short interest ratio of 2.0. Learn More on LifeVantage's short interest ratio.

What is a good short interest percentage for LifeVantage?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.78% of LifeVantage's floating shares are currently sold short.

Is LifeVantage's short interest increasing or decreasing?

LifeVantage saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 78,800 shares, an increase of 16.6% from the previous total of 67,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is LifeVantage's float size?

LifeVantage currently has issued a total of 12,700,000 shares. Some of LifeVantage's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. LifeVantage currently has a public float of 10,080,000 shares.

How does LifeVantage's short interest compare to its competitors?

0.78% of LifeVantage's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to LifeVantage: Oncolytics Biotech Inc. (1.14%), Chimerix, Inc. (1.71%), Barinthus Biotherapeutics plc (0.05%), Milestone Pharmaceuticals Inc. (0.81%), Annovis Bio, Inc. (14.41%), ProPhase Labs, Inc. (1.88%), Spero Therapeutics, Inc. (0.87%), YS Biopharma Co., Ltd. (0.32%), Eton Pharmaceuticals, Inc. (0.36%), Aclaris Therapeutics, Inc. (8.35%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short LifeVantage stock?

Short selling LFVN is an investing strategy that aims to generate trading profit from LifeVantage as its price is falling. LFVN shares are trading up $0.40 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against LifeVantage?

A short squeeze for LifeVantage occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LFVN, which in turn drives the price of the stock up even further.

How often is LifeVantage's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LFVN, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:LFVN) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners